CTEV Claritev Corporation

Subscribe to $CTEV

Claritev Corporation

Subscribe to $CTEV

$CTEV

Business Services

Consumer Discretionary

IPO Year: 2020

Exchange: NYSE

Recent Analyst Ratings for Claritev Corporation

Date	Price Target	Rating	Analyst

See more ratings

Claritev Corporation Press Releases

Fastest customizable press release news feed in the world

Claritev Corporation Reports First Quarter 2025 Results
– Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a
5/8/25 6:00:00 AM ET
$CTEV
Business Services
Consumer Discretionary
Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings
The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint. Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a pow
5/7/25 8:00:00 AM ET
$CTEV
Business Services
Consumer Discretionary
Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks
HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio
5/6/25 10:02:00 AM ET
$CTEV
Business Services
Consumer Discretionary
Claritev Appoints Jason Kap to its Board of Directors
Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generati
5/1/25 8:00:00 AM ET
$CTEV
Business Services
Consumer Discretionary
Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region
Claritev and Claims Care Revenue Cycle Management, a Burjeel Holdings Company, sign an MoU to bring the US-based Claritev's solutions to the MENA region and collaborate on revenue cycle management capabilities Claritev Corporation ("Claritev") (NYSE:CTEV) and Claims Care Revenue Cycle Management LLC ("Claims Care" or "CCRCM"), a division of Burjeel Holdings (ADX: BURJEEL), have signed a memorandum of understanding (MOU) to leverage Claritev's Payment and Revenue Integrity solutions for the Middle East and North Africa regional payer market and create a joint product roadmap to offer advanced revenue cycle management (RCM) capabilities in the region. This press release features multimedia.
4/25/25 8:00:00 AM ET
$CTEV
Business Services
Consumer Discretionary
Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy
Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership team to support the company's strategic growth, transformation and mission to bring transparency to the healthcare ecosystem with innovative products and solutions. Jigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will pro
4/17/25 12:06:00 PM ET
$CTEV
Business Services
Consumer Discretionary
Claritev's Ceres® Named "Data Solution of the Year for Insurance" in 2025 Data Breakthrough Awards Program
Prestigious International Awards Program Recognizes Outstanding Data Technology Products and Companies Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that one of its data and decision science solutions, Ceres®, has been selected as winner of the "Data Solution of the Year for Insurance" award in the 6th annual Data Breakthrough Awards' Industry Applications Category. Data Breakthrough, an independent market intelligence organization, recognizes the top companies, technologies and products in the global data technol
4/14/25 4:45:00 PM ET
$CTEV
Business Services
Consumer Discretionary
Claritev Corporation Announces First Quarter 2025 Earnings Conference Call
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0
4/10/25 8:30:00 AM ET
$CTEV
Business Services
Consumer Discretionary
ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks
Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos
3/12/25 8:03:00 AM ET
$CTEV
$MPLN
Business Services
Consumer Discretionary

Claritev Corporation

Recent Analyst Ratings for Claritev Corporation

Claritev Corporation

Recent Analyst Ratings for Claritev Corporation

Claritev Corporation Financials

Live finance-specific insights

Claritev Corporation Reports First Quarter 2025 Results

Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

Claritev Corporation SEC Filings

SEC Form 10-Q filed by Claritev Corporation

Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Claritev Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

SEC Form DEFA14A filed by Claritev Corporation

SEC Form DEF 14A filed by Claritev Corporation

Claritev Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Claritev Corporation Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Pres., CEO & Executive Chair Dalton Travis bought $100,823 worth of shares (5,252 units at $19.20), increasing direct ownership by 2% to 239,285 units (SEC Form 4)

EVP&CFO Garis Douglas Michael bought $175,891 worth of shares (8,919 units at $19.72) (SEC Form 4)

Claritev Corporation Press Releases

Fastest customizable press release news feed in the world

Claritev Corporation Reports First Quarter 2025 Results

Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

Claritev Appoints Jason Kap to its Board of Directors

Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region

Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy

Claritev's Ceres® Named "Data Solution of the Year for Insurance" in 2025 Data Breakthrough Awards Program

Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

Claritev Corporation Leadership Updates

Live Leadership Updates

Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

Claritev Appoints Jason Kap to its Board of Directors

Claritev Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Kap Jason Lamar was granted 7,356 shares (SEC Form 4)

SEC Form 3 filed by new insider Kap Jason Lamar

Director Klapstein Julie D was granted 7,356 shares, increasing direct ownership by 89% to 15,634 units (SEC Form 4)

Director Prince John Michael was granted 7,356 shares, increasing direct ownership by 138% to 12,685 units (SEC Form 4)

Director Colaluca Anthony Jr was granted 7,356 shares, increasing direct ownership by 92% to 15,357 units (SEC Form 4)

Director Harris C Martin was granted 7,356 shares, increasing direct ownership by 93% to 15,305 units (SEC Form 4)

Director Klein Michael Stuart was granted 7,356 shares, increasing direct ownership by 92% to 15,357 units (SEC Form 4)

Director Clarke Richard A was granted 7,356 shares, increasing direct ownership by 92% to 15,357 units (SEC Form 4)

SVP, General Counsel O'Neil Tara covered exercise/tax liability with 48 shares, decreasing direct ownership by 0.20% to 23,963 units (SEC Form 4)

SVP, Chief Accounting Officer Kozel Gerald covered exercise/tax liability with 74 shares, decreasing direct ownership by 0.13% to 57,815 units (SEC Form 4)